Home/Pipeline/SmartShot

SmartShot

Cartilage Defects (e.g., Knee)

CommercialActive

Key Facts

Indication
Cartilage Defects (e.g., Knee)
Phase
Commercial
Status
Active
Company

About Marrow Access Technologies

Marrow Access Technologies is a private, commercial-stage medical device company focused on enhancing the gold-standard procedure of bone marrow stimulation for cartilage repair. Its flagship SmartShot device is a novel surgical instrument that creates precise channels to access stem cell-rich bone marrow, offering twice the marrow access with significantly less bone disruption than traditional mallet-based microfracture. The company has launched devices for general orthopaedic use and a specific ankle version, targeting a large market of patients with cartilage injuries. Led by a team with extensive medical device experience and guided by a board including key opinion leaders, the company is positioned to capture share in the established marrow stimulation market.

View full company profile